BARCLAYS PLC - LA JOLLA PHARMACEUTICAL CO ownership

LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 29 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of LA JOLLA PHARMACEUTICAL CO
ValueSharesWeighting
Q2 2022$17,000
-26.1%
5,3520.0%0.00%
Q1 2022$23,000
-54.0%
5,352
-50.1%
0.00%
Q4 2021$50,000
+66.7%
10,728
+39.3%
0.00%
Q3 2021$30,000
-51.6%
7,704
-47.1%
0.00%
Q2 2021$62,000
-3.1%
14,567
-3.4%
0.00%
Q1 2021$64,000
+178.3%
15,083
+158.6%
0.00%
Q4 2020$23,000
-32.4%
5,832
-30.5%
0.00%
Q3 2020$34,000
-24.4%
8,395
-21.0%
0.00%
Q2 2020$45,000
+55.2%
10,631
+52.0%
0.00%
Q1 2020$29,000
-65.9%
6,996
-67.9%
0.00%
Q4 2019$85,000
-38.8%
21,820
+38.6%
0.00%
Q3 2019$139,000
+5.3%
15,747
+11.2%
0.00%
Q2 2019$132,000
+222.0%
14,162
+120.1%
0.00%
Q1 2019$41,000
-89.6%
6,433
-84.6%
0.00%
Q4 2018$394,000
-86.4%
41,709
-71.1%
0.00%
-100.0%
Q3 2018$2,903,000
+58.1%
144,208
+129.2%
0.00%0.0%
Q2 2018$1,836,000
+56.8%
62,919
+60.0%
0.00%
+100.0%
Q1 2018$1,171,000
+1215.7%
39,327
+1318.7%
0.00%
Q4 2017$89,000
-74.4%
2,772
-72.3%
0.00%
Q3 2017$348,000
-19.8%
9,993
-31.4%
0.00%
Q2 2017$434,000
+538.2%
14,570
+541.9%
0.00%
Q1 2017$68,000
+1600.0%
2,270
+1007.3%
0.00%
Q4 2016$4,000
-50.0%
205
-40.2%
0.00%
Q3 2016$8,000
+700.0%
343
+491.4%
0.00%
Q2 2016$1,0000.0%580.0%0.00%
Q1 2016$1,000
-75.0%
58
-62.8%
0.00%
Q4 2015$4,000
-98.5%
156
-98.4%
0.00%
Q3 2015$265,000
+5200.0%
9,810
+4338.9%
0.00%
Q2 2015$5,000
-84.4%
221
-93.9%
0.00%
Q2 2014$32,0003,6000.00%
Other shareholders
LA JOLLA PHARMACEUTICAL CO shareholders Q3 2014
NameSharesValueWeighting ↓
TANG KEVIN C 240,000$1,027,00095.09%
TANG CAPITAL MANAGEMENT LLC 10,049,224$43,011,0008.56%
RTW INVESTMENTS, LP 2,327,903$9,963,0000.15%
Boxer Capital, LLC 890,700$3,812,0000.13%
Tibra Equities Europe Ltd 72,600$311,0000.10%
WealthTrust Axiom LLC 25,400$108,0000.04%
GSA CAPITAL PARTNERS LLP 52,749$226,0000.02%
FIRST MIDWEST BANK TRUST DIVISION 34,231$147,0000.02%
HOLLENCREST CAPITAL MANAGEMENT 42,355$181,0000.02%
Summit Global Investments 48,500$208,0000.01%
View complete list of LA JOLLA PHARMACEUTICAL CO shareholders